List of Tables
Table 1. Global mRNA Vaccine Sales (K Doses) Growth Rate Comparison by Type (2015-2026)
Table 2. Global mRNA Vaccine Sales (K Doses) Comparison by Application: 2020 VS 2026
Table 3. Global mRNA Vaccine Market Size by Type (K Doses) (US$ Million) (2020 VS 2026)
Table 4. Global Key mRNA Vaccine Manufacturers Covered in This Study
Table 5. Global mRNA Vaccine Sales (K Doses) by Manufacturers (2015-2020)
Table 6. Global mRNA Vaccine Sales Share by Manufacturers (2015-2020)
Table 7. Global mRNA Vaccine Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global mRNA Vaccine Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market mRNA Vaccine Average Price (USD/Dose) of Key Manufacturers (2015-2020)
Table 10. Manufacturers mRNA Vaccine Sales Sites and Area Served
Table 11. Manufacturers mRNA Vaccine Product Types
Table 12. Global mRNA Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global mRNA Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in mRNA Vaccine as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key mRNA Vaccine Players
Table 16. Global mRNA Vaccine Sales (K Doses) by Region (2015-2020)
Table 17. Global mRNA Vaccine Sales Market Share by Region (2015-2020)
Table 18. Global mRNA Vaccine Revenue (Million US$) by Region (2015-2020)
Table 19. Global mRNA Vaccine Revenue Market Share by Region (2015-2020)
Table 20. North America mRNA Vaccine Sales by Country (2015-2020) (K Doses)
Table 21. North America mRNA Vaccine Sales Market Share by Country (2015-2020)
Table 22. North America mRNA Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 23. North America mRNA Vaccine Revenue Market Share by Country (2015-2020)
Table 24. Europe mRNA Vaccine Sales by Country (2015-2020) (K Doses)
Table 25. Europe mRNA Vaccine Sales Market Share by Country (2015-2020)
Table 26. Europe mRNA Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe mRNA Vaccine Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific mRNA Vaccine Sales by Region (2015-2020) (K Doses)
Table 29. Asia Pacific mRNA Vaccine Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific mRNA Vaccine Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific mRNA Vaccine Revenue Market Share by Region (2015-2020)
Table 32. Latin America mRNA Vaccine Sales by Country (2015-2020) (K Doses)
Table 33. Latin America mRNA Vaccine Sales Market Share by Country (2015-2020)
Table 34. Latin America mRNA Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America mRNA Vaccine Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa mRNA Vaccine Sales by Country (2015-2020) (K Doses)
Table 37. Middle East and Africa mRNA Vaccine Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa mRNA Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa mRNA Vaccine Revenue Market Share by Country (2015-2020)
Table 40. Global mRNA Vaccine Sales (K Doses) by Type (2015-2020)
Table 41. Global mRNA Vaccine Sales Share by Type (2015-2020)
Table 42. Global mRNA Vaccine Revenue (Million US$) by Type (2015-2020)
Table 43. Global mRNA Vaccine Revenue Share by Type (2015-2020)
Table 44. Global mRNA Vaccine Price (USD/Dose) by Type (2015-2020)
Table 45. Global mRNA Vaccine Sales (K Doses) by Application (2015-2020)
Table 46. Global mRNA Vaccine Sales Market Share by Application (2015-2020)
Table 47. Global mRNA Vaccine Sales Growth Rate by Application (2015-2020)
Table 48. Moderna Therapeutics mRNA Vaccine Corporation Information
Table 49. Moderna Therapeutics Description and Business Overview
Table 50. Moderna Therapeutics mRNA Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 51. Moderna Therapeutics Main Product
Table 52. Moderna Therapeutics Recent Development
Table 53. CureVac mRNA Vaccine Corporation Information
Table 54. CureVac Corporation Information
Table 55. CureVac mRNA Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 56. CureVac Main Product
Table 57. CureVac Recent Development
Table 58. Translate Bio mRNA Vaccine Corporation Information
Table 59. Translate Bio Corporation Information
Table 60. Translate Bio mRNA Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 61. Translate Bio Main Product
Table 62. Translate Bio Recent Development
Table 63. BioNTech mRNA Vaccine Corporation Information
Table 64. BioNTech Corporation Information
Table 65. BioNTech mRNA Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 66. BioNTech Main Product
Table 67. BioNTech Recent Development
Table 68. Sangamo Therapeutics mRNA Vaccine Corporation Information
Table 69. Sangamo Therapeutics Corporation Information
Table 70. Sangamo Therapeutics mRNA Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 71. Sangamo Therapeutics Main Product
Table 72. Sangamo Therapeutics Recent Development
Table 73. Argos Therapeutics mRNA Vaccine Corporation Information
Table 74. Argos Therapeutics Corporation Information
Table 75. Argos Therapeutics mRNA Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 76. Argos Therapeutics Main Product
Table 77. Argos Therapeutics Recent Development
Table 78. In-Cell-Art mRNA Vaccine Corporation Information
Table 79. In-Cell-Art Corporation Information
Table 80. In-Cell-Art mRNA Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 81. In-Cell-Art Main Product
Table 82. In-Cell-Art Recent Development
Table 83. eTheRNA mRNA Vaccine Corporation Information
Table 84. eTheRNA Corporation Information
Table 85. eTheRNA mRNA Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 86. eTheRNA Main Product
Table 87. eTheRNA Recent Development
Table 88. Ethris mRNA Vaccine Corporation Information
Table 89. Ethris Corporation Information
Table 90. Ethris mRNA Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 91. Ethris Main Product
Table 92. Ethris Recent Development
Table 93. Tiba Biotechnology mRNA Vaccine Corporation Information
Table 94. Tiba Biotechnology Corporation Information
Table 95. Tiba Biotechnology mRNA Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 96. Tiba Biotechnology Main Product
Table 97. Tiba Biotechnology Recent Development
Table 98. Sales Base and Market Concentration Rate of Raw Material
Table 99. Key Suppliers of Raw Materials
Table 100. mRNA Vaccine Distributors List
Table 101. mRNA Vaccine Customers List
Table 102. Market Key Trends
Table 103. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 104. Key Challenges
Table 105. Global mRNA Vaccine Sales (K Doses) Forecast by Type (2021-2026)
Table 106. Global mRNA Vaccine Sales Market Share Forecast by Type (2021-2026)
Table 107. Global mRNA Vaccine Revenue (Million US$) Forecast by Type (2021-2026)
Table 108. Global mRNA Vaccine Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 109. Global mRNA Vaccine Sales (K Doses) Forecast by Application (2021-2026)
Table 110. Global mRNA Vaccine Revenue (Million US$) Forecast by Application (2021-2026)
Table 111. Global mRNA Vaccine Sales (K Doses) Forecast by Region (2021-2026)
Table 112. Global mRNA Vaccine Sales Market Share Forecast by Region (2021-2026)
Table 113. Global mRNA Vaccine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 114. Global mRNA Vaccine Revenue Market Share Forecast by Region (2021-2026)
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of mRNA Vaccine
Figure 2. Global mRNA Vaccine Sales Market Share by Type: 2020 VS 2026
Figure 3. Standardization Of Cancer Treatment MRNA Vaccine Product Picture
Figure 4. Individualized Cancer Treatment MRNA Vaccine Product Picture
Figure 5. Infectious Disease Treatment MRNA Vaccine Product Picture
Figure 6. Infection Prevention MRNA Vaccine Product Picture
Figure 7. Global mRNA Vaccine Consumption Market Share by Application: 2020 VS 2026
Figure 8. Infectious Disease
Figure 9. Cancer
Figure 10. Other
Figure 11. Global mRNA Vaccine Market Size 2015-2026 (US$ Million)
Figure 12. Global mRNA Vaccine Sales Capacity (K Doses) (2015-2026)
Figure 13. Global mRNA Vaccine Market Size Market Share by Region: 2020 Versus 2026
Figure 14. mRNA Vaccine Sales Share by Manufacturers in 2020
Figure 15. Global mRNA Vaccine Revenue Share by Manufacturers in 2019
Figure 16. The Global 5 and 10 Largest Players: Market Share by mRNA Vaccine Revenue in 2019
Figure 17. mRNA Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 18. Global mRNA Vaccine Sales Market Share by Region (2015-2020)
Figure 19. Global mRNA Vaccine Sales Market Share by Region in 2019
Figure 20. Global mRNA Vaccine Revenue Market Share by Region (2015-2020)
Figure 21. Global mRNA Vaccine Revenue Market Share by Region in 2019
Figure 22. North America mRNA Vaccine Sales Market Share by Country in 2019
Figure 23. North America mRNA Vaccine Revenue Market Share by Country in 2019
Figure 24. U.S. mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 25. U.S. mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 26. Canada mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 27. Canada mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 28. Europe mRNA Vaccine Sales Market Share by Country in 2019
Figure 29. Europe mRNA Vaccine Revenue Market Share by Country in 2019
Figure 30. Germany mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 31. Germany mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 32. France mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 33. France mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. U.K. mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 35. U.K. mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Italy mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 37. Italy mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Russia mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 39. Russia mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Asia Pacific mRNA Vaccine Sales Market Share by Region in 2019
Figure 41. Asia Pacific mRNA Vaccine Revenue Market Share by Region in 2019
Figure 42. China mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 43. China mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. Japan mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 45. Japan mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. South Korea mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 47. South Korea mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. India mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 49. India mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Australia mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 51. Australia mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Taiwan mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 53. Taiwan mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Indonesia mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 55. Indonesia mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Thailand mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 57. Thailand mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Malaysia mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 59. Malaysia mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Philippines mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 61. Philippines mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Vietnam mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 63. Vietnam mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Latin America mRNA Vaccine Sales Market Share by Country in 2019
Figure 65. Latin America mRNA Vaccine Revenue Market Share by Country in 2019
Figure 66. Mexico mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 67. Mexico mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Brazil mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 69. Brazil mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Argentina mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 71. Argentina mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Middle East and Africa mRNA Vaccine Sales Market Share by Country in 2019
Figure 73. Middle East and Africa mRNA Vaccine Revenue Market Share by Country in 2019
Figure 74. Turkey mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 75. Turkey mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Saudi Arabia mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 77. Saudi Arabia mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. U.A.E mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 79. U.A.E mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Sales Market Share of mRNA Vaccine by Type (2015-2020)
Figure 81. Sales Market Share of mRNA Vaccine by Type in 2019
Figure 82. Revenue Share of mRNA Vaccine by Type (2015-2020)
Figure 83. Revenue Market Share of mRNA Vaccine by Type in 2019
Figure 84. Global mRNA Vaccine Sales Growth by Type (2015-2020) (K Doses)
Figure 85. Global mRNA Vaccine Sales Market Share by Application (2015-2020)
Figure 86. Global mRNA Vaccine Sales Market Share by Application in 2019
Figure 87. Global Revenue Share of mRNA Vaccine by Application (2015-2020)
Figure 88. Global Revenue Share of mRNA Vaccine by Application in 2020
Figure 89. Moderna Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. CureVac Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Translate Bio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. BioNTech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Sangamo Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Argos Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. In-Cell-Art Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. eTheRNA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Ethris Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Tiba Biotechnology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. Price Trend of Key Raw Materials
Figure 100. Manufacturing Cost Structure of mRNA Vaccine
Figure 101. Manufacturing Process Analysis of mRNA Vaccine
Figure 102. mRNA Vaccine Industrial Chain Analysis
Figure 103. Channels of Distribution
Figure 104. Distributors Profiles
Figure 105. Porter's Five Forces Analysis
Figure 106. North America mRNA Vaccine Sales (K Doses) and Growth Rate Forecast (2021-2026)
Figure 107. North America mRNA Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 108. Europe mRNA Vaccine Sales (K Doses) and Growth Rate Forecast (2021-2026)
Figure 109. Europe mRNA Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 110. Latin America mRNA Vaccine Sales (K Doses) and Growth Rate Forecast (2021-2026)
Figure 111. Latin America mRNA Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 112. Middle East and Africa mRNA Vaccine Sales (K Doses) and Growth Rate Forecast (2021-2026)
Figure 113. Middle East and Africa mRNA Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 114. Asia Pacific mRNA Vaccine Sales (K Doses) and Growth Rate Forecast (2021-2026)
Figure 115. Asia Pacific mRNA Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 116. Bottom-up and Top-down Approaches for This Report
Figure 117. Data Triangulation
Figure 118. Key Executives Interviewed